{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:08Z","timestamp":1786654028964,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002904","name":"Taian City People's Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejphar.2026.179179","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:14:40Z","timestamp":1785168880000},"page":"179179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway"],"prefix":"10.1016","volume":"1031","author":[{"given":"Changwei","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179179_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management","volume":"20","author":"Argiles","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179179_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2026.179179_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia \u2014 understanding the tumour macroenvironment and microenvironment to improve management","author":"Argil\u00e9s","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179179_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-021-00624-w","article-title":"The interplay of immunology and cachexia in infection and cancer","author":"Baazim","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2026.179179_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.179179_bib6","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1038\/s41467-021-26407-4","article-title":"Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy","volume":"12","author":"Bent","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179179_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-024-01167-9","article-title":"Cancer cachexia: multilevel metabolic dysfunction","author":"Berriel Diaz","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejphar.2026.179179_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.clnu.2010.06.003","article-title":"Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia","volume":"29","author":"Busquets","year":"2010","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejphar.2026.179179_bib9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.metabol.2013.05.018","article-title":"Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes","volume":"62","author":"Castillero","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2026.179179_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113066","article-title":"Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway","author":"Chen","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.179179_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1249\/MSS.0000000000002772","article-title":"Early-onset physical inactivity and metabolic dysfunction in tumor-bearing mice is associated with accelerated cachexia","volume":"54","author":"Counts","year":"2022","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.ejphar.2026.179179_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2025.01.018","article-title":"MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia","author":"Cui","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2026.179179_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: a systemic consequence of progressive, unresolved disease","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179179_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091327","article-title":"Out of control: the role of the ubiquitin proteasome system in skeletal muscle during inflammation","volume":"11","author":"Haberecht-Muller","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179179_bib15","series-title":"Imaging Modalities for Diagnosis and Monitoring of Cancer Cachexia","author":"Han","year":"2021"},{"key":"10.1016\/j.ejphar.2026.179179_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2416453","article-title":"GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models","author":"Huang","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.ejphar.2026.179179_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14030879","article-title":"Examining patient characteristics in bladder cancer clinical trials involving immunotherapy","volume":"14","author":"Ikhapoh","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2026.179179_bib18","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.2147\/IJN.S459510","article-title":"Evodiamine: a extremely potential drug development candidate of alkaloids from Evodia rutaecarpa","volume":"19","author":"Lin","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2026.179179_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2013.06.004","article-title":"Evodiamine, a plant alkaloid, induces calcium\/JNK-mediated autophagy and calcium\/mitochondria-mediated apoptosis in human glioblastoma cells","volume":"205","author":"Liu","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.179179_bib20","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179179_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/SPC.0000000000000580","article-title":"Cachexia and bladder cancer: clinical impact and management","volume":"15","author":"Lokeshwar","year":"2021","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.ejphar.2026.179179_bib22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK\/STAT pathway in skeletal muscle pathophysiology","volume":"10","author":"Moresi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2026.179179_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102317","article-title":"Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179179_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132364","article-title":"Defining and addressing research priorities in cancer cachexia through transdisciplinary collaboration","volume":"16","author":"Park","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179179_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186663","article-title":"MuRF1\/TRIM63, master regulator of muscle mass","volume":"21","author":"Peris-Moreno","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179179_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2026.179179_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153858","article-title":"Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway","author":"Shen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.179179_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41392-025-02331-7","article-title":"Cancer cachexia: molecular basis and therapeutic advances","volume":"11","author":"Tan","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179179_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2449586","article-title":"The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia","author":"Thibaut","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2026.179179_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179179_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7811","article-title":"Cucurbitacin IIB attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6\/STAT3\/FOXO signaling pathway","author":"Wang","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2026.179179_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103500","article-title":"Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial","volume":"88","author":"Yamamoto","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejphar.2026.179179_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12246","article-title":"Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia","author":"Yang","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2026.179179_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179179_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1551561","article-title":"Mechanisms, assessment, and exercise interventions for skeletal muscle dysfunction post-chemotherapy in breast cancer: from inflammation factors to clinical practice","volume":"15","author":"Zhong","year":"2025","journal-title":"Front. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:14:47Z","timestamp":1786652087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0014299926006618"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179179","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179179"}}